Youngy Health Co., Ltd.
Szimbólum: 300247.SZ
SHZ
2.97
CNYMai piaci árfolyam
68.1562
P/E arány
4.6551
PEG-arány
2.39B
MRK Cap
- 0.00%
DIV hozam
Youngy Health Co., Ltd. (300247-SZ) Pénzügyi kimutatások
Mérleg
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 493.1 | 409.3 | 235.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 374 | 341 | 144.3 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 51.8 | 54.3 | 65.6 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 143.9 | 186.6 | 149.2 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 129.2 | 116.5 | 51 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 818 | 766.7 | 501.4 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 224.9 | 246.1 | 259.4 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 42.8 | 44.9 | 55.5 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 42.8 | 44.9 | 55.5 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | -323 | -290.1 | -10.9 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 7 | 3.1 | 1.9 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 451.9 | 416.1 | 214.7 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 403.5 | 420.1 | 520.7 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1221.6 | 1186.8 | 1022.2 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 47.4 | 52.7 | 52 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 12 | 10.4 | 7 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 2.7 | 3.6 | 2.7 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5.4 | 17 | 25.1 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | -19.1 | -15.9 | 0.1 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 1.7 | 2.4 | 1.9 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 24.5 | 32.9 | 33.2 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5.4 | 17 | 25.1 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 148.9 | 158 | 161.1 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 804 | 804 | 804 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1200.1 | -1226.7 | -1353 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 45.1 | 66.5 | 35.3 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1367.7 | 1345.1 | 1345.1 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1016.8 | 989 | 831.4 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1221.6 | 1186.8 | 1022.2 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 55.9 | 39.8 | 29.7 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1072.7 | 1028.8 | 861.1 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 50.9 | 50.9 | 133.4 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 17.3 | 27.4 | 32.1 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | -101.8 | -40.9 | -59.2 |
Cash Flow kimutatás
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 133.3 | 31.4 | -55.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 28.4 | 22.6 | 18.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 6.7 | 1.9 | 1.1 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -6.7 | -1.9 | -1.1 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -51.9 | -18.9 | 75.4 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | -14.7 | 15.9 | 24.1 | |||||||||||||||||
cash-flows.row.inventory | 0 | -40 | -44 | 3.2 | |||||||||||||||||
cash-flows.row.account-payables | 0 | -3.9 | 7.4 | 47 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 6.7 | 1.9 | 1.1 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -139.1 | -24.3 | 42.3 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -17.5 | -6.2 | -8.7 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.2 | 0.2 | 35.5 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -800.7 | -374.7 | -355.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 805.5 | 256.5 | 368.4 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 19.1 | 55 | 0.5 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 7.6 | -69.3 | 39.8 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -11.6 | -5.7 | -25 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.9 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -11.6 | -5.7 | -10.8 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -11.6 | -5.7 | -36.7 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 10.1 | -4.5 | -10.1 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -23 | -68.7 | 73.9 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 68.3 | 91.3 | 160 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 91.3 | 160 | 86.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -29.2 | 10.8 | 81 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -17.5 | -6.2 | -8.7 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -46.7 | 4.6 | 72.3 |
Eredménykimutatás sor
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 529.4 | 463.3 | 526.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 355.5 | 352 | 399.3 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 174 | 111.3 | 127.2 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 13.7 | 4 | 15.3 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 132.2 | 119.2 | 112.2 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 487.6 | 471.2 | 511.5 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 7.9 | 2.9 | 2.5 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0.6 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 0.3 | -0.8 | -0.5 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 13.7 | 4 | 15.3 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 0.3 | -0.8 | -0.5 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0.6 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 28 | 28.4 | 22.6 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | 59.4 | 137.2 | 38.3 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 59.8 | 136.4 | 37.8 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 17.8 | 3.1 | 6.3 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | 26.6 | 126.3 | 24.2 |
Gyakran ismételt kérdés
Mi a Youngy Health Co., Ltd. (300247.SZ) az összes eszköz?
Youngy Health Co., Ltd. (300247.SZ) az összes eszköz 1221559067.000.
Mekkora a vállalkozás éves bevétele?
Az éves bevétel N/A.
Mennyi a cég haszonkulcsa?
A cég haszonkulcsa 0.332.
Mennyi a vállalat szabad cash flow-ja?
A szabad pénzáramlás 0.115.
Mi a vállalati nettó haszonkulcs?
A nettó haszonkulcs 0.066.
Mennyi a vállalat teljes bevétele?
A teljes bevétel 0.130.
Mi a Youngy Health Co., Ltd. (300247.SZ) nettó profit (nettó nyereség)?
A nettó nyereség (nettó bevétel) 26582643.000.
Mennyi a cég teljes adóssága?
Az összes adósság 17332369.000.
Mi a működési költségek száma?
A működési költségek 132173058.000.
Mennyi a cég készpénzállománya?
A vállalati pénzeszközök 0.000.